| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,550 | 6,000 | 18:00 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 22,200 | 30 | |||
| 19,600 | 2 | |||
| 16,000 | 500 | |||
| 15,000 | 15 | |||
| 6,000 | 1.230 | |||
| 5,900 | 728 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 1.958 | 5,550 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.019 | 0,832 | 2.511 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 21.04.2026 | 09:25:48 | 5,500 | 3 |
| Tagesumsatz Xetra | 0,000 0,00 % | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | 4BaseBio expands facilities to support growing synthetic DNA demand | 18 | Alliance News | ||
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 31.03. | 4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK | 168 | GlobeNewswire (Europe) | 4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 - 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces... ► Artikel lesen | |
| 31.03. | 4basebio Plc - Lease of Manufacturing Facility | 350 | PR Newswire | 4basebio Plc - Lease of Manufacturing Facility
PR Newswire
LONDON, United Kingdom, March 31
4basebio... ► Artikel lesen | |
| 12.03. | IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer | 5 | Alliance News | ||
| 12.03. | 4basebio Plc - Appointment of COO | 401 | PR Newswire | 4basebio Plc - Appointment of COO
PR Newswire
LONDON, United Kingdom, March 12
THIS... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 12:51 | EQS-Media: Erfolgreicher Analytik-Meilenstein erreicht: Onco-Innovations stärkt "ONC010"-Plattform | EQS Group (DE) | EQS-Media / 22.04.2026 / 12:49 CET/CEST
Onco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco oder das Unternehmen, gibt den erfolgreichen Abschluss eines bedeutenden Meilensteins mit... ► Artikel lesen | |
| 13:15 | Marinomed erschließt Rezepturarzneimittel als neues Geschäftsfeld | 4investors | Die österreichische Marinomed Biotech AG plant den Einstieg in die Zulieferung für Rezepturarzneimittel, also individuell für einzelne Patienten angepasste Arzneimittel. Grundlage ist die unternehmenseigene... ► Artikel lesen | |
| 13:10 | Following Stryker Cyberattack, Avatier Launches Identity Challenge Card to Protect Organizations When Standard Security Fails | GlobeNewswire (Europe) | New Solution Delivers the First Auto-Enrolled, Air-Gapped Multi-Factor Authentication (MFA) That Can Be Deployed Enterprise-Wide in a Single Day: No Devices, Apps, or Network Connectivity RequiredPLEASANTON... ► Artikel lesen | |
| 15:30 | Morning Market Movers: Axe Compute, Inhibrx Biosciences, Huachen AI Parking Management Technology, 1-800-FLOWERS.COM See Big Swings | AFX News | OTTAWA (dpa-AFX) - At 9:00 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 13:06 | Precision BioSciences, Inc.: Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026 | Business Wire | Late-breaking poster presentation to highlight new biopsy data demonstrating elimination and inactivation of cccDNA from the ongoing Phase 1 ELIMINATE-B trial in chronic hepatitis B
Precision... ► Artikel lesen |